{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T10:12:33Z","timestamp":1725617553457},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T00:00:00Z","timestamp":1324598400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00296-011-2267-2","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T09:57:19Z","timestamp":1324547839000},"page":"3881-3886","source":"Crossref","is-referenced-by-count":7,"title":["Reevaluation of predictive value of ACL and anti-\u03b22GP1 antibody for thrombosis in patients with systemic lupus erythematosus: from a perspective of a practical world"],"prefix":"10.1007","volume":"32","author":[{"given":"Xiaoli","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,23]]},"reference":[{"issue":"2","key":"2267_CR1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295\u2013306","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2267_CR2","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","volume":"102","author":"M Galli","year":"2003","unstructured":"Galli M, Luciani D, Bertolini G et al (2003) Anti-beta2-glycoproteinI, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102(8):2717\u20132723","journal-title":"Blood"},{"key":"2267_CR3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.thromres.2004.06.034","volume":"14","author":"G Reber","year":"2004","unstructured":"Reber G, de Moerloose P (2004) Anti-beta2-glycoprotein I antibodies\u2014when and how should they be measured? Thromb Res 14:527\u2013531","journal-title":"Thromb Res"},{"key":"2267_CR4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/HAB-2003-12301","volume":"12","author":"I Marai","year":"2003","unstructured":"Marai I, Gilburd B, Blank M et al (2003) Anti-cardiolipin and anti-\u03b22-glycoprotein I (\u03b22GP-I) antibody assays as screening for anti-phospholipid syndrome. Human Antibodies 12:57\u201362","journal-title":"Human Antibodies"},{"issue":"13","key":"2267_CR5","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1182\/blood-2005-05-2048","volume":"106","author":"M Christoph","year":"2005","unstructured":"Christoph M, Denise F, Hugh H et al (2005) Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 106(13):4152\u20134158","journal-title":"Blood"},{"issue":"12","key":"2267_CR6","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/j.1538-7836.2007.02763.x","volume":"5","author":"PL Meroni","year":"2007","unstructured":"Meroni PL, Peyvandi F, Foco L et al (2007) Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women. J Thromb Haemost 5(12):2421\u20132428","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2267_CR7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.amjcard.2007.12.010","volume":"101","author":"I Marai","year":"2008","unstructured":"Marai I, Shechter M, Langevitz P et al (2008) Anti-cardiolipin antibodies and endothelial function in patients with coronary artery disease. Am J Cardiol 101(8):1094\u20131097","journal-title":"Am J Cardiol"},{"key":"2267_CR8","doi-asserted-by":"crossref","unstructured":"Arad A, Proulle V, Furie RA et al (2011) {beta}2 glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. Blood Jan 18. [Epub ahead of print]","DOI":"10.1182\/blood-2010-08-300715"},{"issue":"5","key":"2267_CR9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.arcmed.2004.05.006","volume":"35","author":"A Lavalle-Graef","year":"2004","unstructured":"Lavalle-Graef A, Villegas-Acosta L, Lavalle C (2004) Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus. Arch Med Res 35(5):421\u2013427","journal-title":"Arch Med Res"},{"key":"2267_CR10","unstructured":"Amelia R, Teresa Del R, Manuela C et al (2011) Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. Ann Rheum Dis Feb 1. [Epub ahead of print]"},{"issue":"2","key":"2267_CR11","first-page":"63","volume":"94","author":"P Sarzi-Puttini","year":"2003","unstructured":"Sarzi-Puttini P, Atzeni F, Carrabba M (2003) Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome. Minerva Med 94(2):63\u201370","journal-title":"Minerva Med"},{"key":"2267_CR12","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"2267_CR13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-199303000-00005","volume":"72","author":"R Cervera","year":"1993","unstructured":"Cervera R, Khamashta MA, Front J et al (1993) Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. Medicine (Baltimore) 72:113\u2013124","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2267_CR14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12016-007-0009-8","volume":"32","author":"T Tarr","year":"2007","unstructured":"Tarr T, Lakos G, Bhattoa HP et al (2007) Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up. Clin Rev Allergy Immunol 32(2):131\u2013137","journal-title":"Clin Rev Allergy Immunol"},{"key":"2267_CR15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295\u2013306","journal-title":"J Thromb Haemost"},{"key":"2267_CR16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0165-0378(93)90076-T","volume":"24","author":"AM Bahar","year":"1993","unstructured":"Bahar AM, Kwak JY, Beer AE et al (1993) Antibodies to phospholipids and nuclear antigens in non-pregnant women with unexplained spontaneous recurrent abortions. J Reprod Immunol 24:213\u2013222","journal-title":"J Reprod Immunol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2267-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2267-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2267-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T06:21:45Z","timestamp":1561098105000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2267-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,23]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2267"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2267-2","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,23]]}}}